Cost-effectiveness of photobiomodulation therapy for the prevention and management of cancer treatment toxicities: a systematic review.
Elisa Kauark FontesLeticia Rodrigues-OliveiraJoel B EpsteinKarina Morais FariaAnna Luíza Damaceno AraújoLuiz Alcino Monteiro GueirosCésar Augusto MiglioratiRamzi George SalloumPatricia BurtonJames CarrollMárcio Ajudarte LopesCarolina Guimarães Bonfim AlvesNatália Rangel PalmierAna Carolina Prado RibeiroThaís Bianca BrandãoAlan Roger Dos Santos SilvaPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)
There is limited evidence that PBM therapy is cost-effective in the prevention and treatment of specific cancer treatment-related toxicities, namely, OM and breast cancer-related lymphedema. Studies may have underreported the benefits due to a lack of a comprehensive cost evaluation. This suggests a wider acceptance of PBM therapy at cancer treatment centers, which has thus far been limited by the number of robust clinical studies that demonstrate cost-effectiveness for the prevention and treatment of toxicities.